Selenium and viral diseases: Facts and hypotheses

Journal of Orthomolecular Medicine

Volumn 12, Issue 4, 1997, Pages 227-239

  Taylor, Ethan Will ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000199160     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Taylor EW, Ramanathan CS, Jalluri RK, Nadimpalli RG: A basis for new approaches to the chemotherapy of AIDS: novel genes in HIV-1 potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression. J Med Chem, 1994; 37: 2637-2654.
2. Beck MA, Shi Q, Morris VC, Levander OA: Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med, 1995; 1: 433-436.
3. Clark LC, Combs GF Jr, Turnbull BW, et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin - a randomized controlled trial. J Amer Med Assoc, 1996; 276: 1957-1963.
4. Schrauzer GN, Sacher J: Selenium in the maintenance and therapy of HIV-infected patients. Chem-Biol Interact, 1994; 91: 199-205.
5. Kiremidjian-Schumacher L, Roy M, Wishe HI, et al: Regulation of cellular immune response by selenium. Biol Trace Elem Res, 1992; 33: 23-35.
6. Turner RJ, Finch JM: Selenium and the immune response. Proc Nutr Soc, 1991; 50: 275-285.
7. Taylor EW: Selenium and cellular immunity: evidence that selenoproteins may be encoded in the +1 reading frame overlapping the human CD4, CD8 and HLA-DR genes. Biol Trace Element Res, 1995; 49: 85-95.
8. Guimaraes MJ, Peterson D, Vicari A, et al: Identification of a novel selD homolog from eukaryotes, bacteria, and archaea: is there an autoregulatory mechanism in selenocysteine metabolism? Proc Natl Acad Sci USA, 1996; 93:15086-15091.
9. Roy M, Kiremidjian-Schumacher L, Wishe HI, et al: Selenium supplementation enhances the expression of interleukin 2 receptor subunits and internalization of interleukin 2. Proc Soc Exp Biol Med, 1993; 202: 295-301.
10. Dworkin BM, Wormser GP, Rosenthal WS, et al: Gastrointestinal manifestations of the acquired immunodeficiency syndrome: a review of 22 cases. Am J Gastroenterol, 1985; 80: 774-778.
11. Dworkin BM, Rosenthal WS, Wormser GP, Weiss L: Selenium deficiency in the acquired immunodeficiency syndrome J Parenter Enteral Nutr, 1986; 10: 405-407.
12. Zazzo JF, Chalas J, Lafont A, et al: Is non-obstructive cardiomyopathy in AIDS a selenium deficiency-related disease? J Parenter Enteral Nutr, 1988; 12: 537-538.
13. Dworkin BM, Rosenthal WS, Wormser GP, et al: Abnormalities of blood selenium and glutathione peroxidase activity in parients with acquired immunodeficiency syndrome and AIDS-related complex. Biol Trace Elem Res, 1988; 15: 167-177.
14. Dworkin BM, Antonecchia PP, Smith F, et al: Reduced cardiac selenium content in the acquired immunodeficiency syndrome. J Parenter Enteral Nutr, 1989; 13: 644-647.
15. Fuchs J, Schofer H, Ochsendorf F, et al: Antioxidants and peroxidation products in the blood of HIV-1-infected patients with HIV-associated skin diseases. Eur J Dermatol, 1994; 4: 148-153.
16. Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J: Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Element Res, 1989; 20: 59-65.
17. Beck KW, Schramel P, Hedl A, et al: Serum trace element levels in HIV-infected subjects. Biol Trace Element Res, 1990; 25: 89-96.
18. Kavanaugh-McHugh AL, Ruff A, Perlman E, et al: Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome. J Parenter Enteral Nutr, 1991; 15: 347-349.
19. Cirelli A, Ciardi M, de-Simone C, et al: Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem, 1991; 24: 211-214.
20. Allavena C, Dousset B, May T, et al: Are zinc and selenium markers of worsening in HIV infected subjects? Presse Med, 1991; 20: 1737.
21. Mantero-Atienza E, Beach RS, Gavancho MC, et al: Selenium status of HIV-1 infected individuals. J Parenter Enteral Nutr, 1991; 15: 693-694.
22. Revillard JP, Vincent CM, Favier AE, et al: Lipid peroxidation in human immunodeficiency virus infection. J AIDS, 1992; 5: 637-638.
23. Constans J, Pellegrin JL, Peuchant E, et al: Membrane fatty acids and blood antioxidants in 77 patients with HIV infection. Rev Med Interne, 1993; 14: 1003.
24. Favier A, Sappey C, Leclerc C, et al: Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact, 1994; 91: 165-180.
25. Dworkin BM: Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chemico-Biol Interact, 1994; 91: 181-186.
26. Bologna R, Indacochea F, Shor-Posner G, et al: Selenium and immunity in HIV-1 infected pediatric patients. J Ntr Immunol, 1994; 3: 41-49.
27. Sergeant C, Simonoff M, Hamon C, et al: Plasma antioxidant status (selenium, retinol and -tocopherol) in HIV infection. In Oxidative stress, cell activation and viral infection, C Pasquier et al, Eds. Basel. Birkhauser Verlag. 1994; p 341-351.
28. Schumacher M, Peraire J, Domingo JL, et al: Trace elements in patients with HIV-1 infection. Trace Elem Electrolytes, 1994; 11: 130-134.
29. Allavena C, Dousset B, May T, et al: Relationship of trace element, immunological markers, and HIV infection progression. Biol Trace Element Res, 1995; 47: 133-138.
30. Constans J, Pellegrin JL, Sergeant C, et al: Serum selenium predicts outcome in HIV infection. J AIDS Human Retrovirol, 1995; 10: 392.
31. Baum MK, Shor-Posner G, Lai S, et al: High risk of HIV-related mortality is associated with selenium deficiency. J AIDS Human Retrovirol, 1997; 15: 370-374.
32. Sandstrom PA, Tebbey PW, Van Cleave S, Buttke TM: Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxide deficiency. J Biol Chem, 1994; 269: 798-801.
33. Sappey C, Legrand-Poels S, Best-Belpomme M, et al: Stimulation of glutathione peroxidase activity decreases HIV Type 1 activation after oxidative stress. AIDS Res Human Retrovir, 1994; 10: 1451-1461.
34. Taylor EW, Ramanathan CS, Nadimpalli RG, Schinazi RF: Do some viruses encode selenoproteins? Assessment of the theory in the light of current theoretical, experimental and clinical dat. Antiviral Res, 1995; 26: A271, #86.
35. Rascati RJ: Induction of retrovirus expression by selenium compounds. Mutat Res, 1983; 117: 67-78.
36. LoPresti JS, Fried JC, Spencer CA, Nicoloff JT: Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med, 1989; 110: 970-975.
37. Bourdoux PP, De-Wit SA, Servais GM, et al: Biochemical thyroid profile in patients infected with the human immunodeficiency virus. Thyroid, 1991; 1: 147-149.
38. Nduwayo L, Nsabiyumva F, Osorio-Salazar C, et al: Endocrinological aspects of acquired immunodeficiency syndrome (AIDS). Med Trop Mars, 1992; 52: 139-143.
39. Grunfeld C, Pang M, Doerrler W, et al: Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism, 1993; 42: 1270-1276.
40. Byamungu N, Mol K, Kuhn ER: Somatostatin increases plasma T3 concentrations in Tilapia nilotica in the presence of increased plasma T4 levels. Gen Comp Endocrinol, 1991; 82: 401-406.
41. Geelhoed-Duijvestijn PH, Roelfsema F, Schroder-van-der-Elst JP, et al: Effect of administration of growth hormone on plasma and intracellular levels of thyroxine and triiodothyronine in thyroidectomized thyroxine-treated rats. J Endocrinol, 1992; 133: 45-49.
42. Yu SY, Li WG, Zhu YJ, et al: Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol Trace Element Res, 1989; 20: 15-22.
43. Yu SY, Zhu YJ, Li WG, et al: A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Element Res, 1991; 29: 289-294.
44. Bai J, Wu S, Ge K, et al: The combined effect of selenium deficiency and viral infection on the myocardium of mice. Acta Acad Med Sin, 1980; 2: 29-31.
45. Beck MA, Kolbeck PC, Rohr LH, et al: Benign human enterovirus becomes virulent in selenium-deficient mice. J Med Virol, 1994; 43: 166-170.
46. Taylor EW, Nadimpalli RG, Ramanathan CS: Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol Trace Element Res, 1997; 56: 63-91.
47. Taylor EW, Ramanathan CS, Nadimpalli RG: A general method for predicting new genes in nucleic acid sequences: application to the human immunodeficiency virus. In Computational Medicine, Public Health and Biotechnology, Witten M, Ed. Singapore. World Scientific. Ser Math Biol Med, 1996; 5: 285-309.
48. Taylor EW, Ramanathan CS: Theoretical evidence that the Ebola virus Zaire strain maybe selenium dependent: a factor in pathogenesis and viral outbreaks? J Orthomolecular Med, 1995; 10: 131-138.
49. Ramanathan CS, Taylor EW: Computational genomic analysis of hemorrhagic fever viruses: viral selenoproteins as a potential factor in pathogenesis. Biol Trace Element Res, 1997; 56: 93-106.
50. Meydani M: Modulation of the platelet thromboxane A2 and aortic prostacyclin synthesis by dietary selenium and vitamin E. Biol Trace Element Res, 1992; 33: 79-86.
51. Hou JC: Inhibitory effect of selenite and other antioxidants on complement-mediated tissue injury in patients with epidemic hemorrhagic fever. Biol Trace Element Res, 1997; 56: 125-130.
52. Senkevich TG, Bugert JJ, Sisler JR, et al: Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science, 1996; 273: 813-816.
53. Ziegler JL: Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet, 1993; 342: 1348-1351.
54. Chariot P, Dubreuil-Lemaire M-L, Zhou JY: Muscle involvement in HIV-infected patients is associated with marked selenium deficiency. Muscle & Nerve, 1997; 20: 386-389.
55. Battigello J-M A, Cui M, Roshong S, Carter B: Enediyne-mediated cleavage of RNA. Bioorg Med Chem, 1995; 3: 839-849.
56. Taylor EW, Nadimpalli RG, Ramanathan CS, et al: Novel isoforms of HIV-1 nef are expressed by frameshifting and selenium-dependent suppression of UGA termination codons. Antiviral Res, 1997; 34(2): A48, #23.
57. Taylor EW, Bhat A, Nadimpalli RG, et al: HIV-1 encodes a sequence overlapping env gp41 with highly significant similarity to selenium-dependent glutathione peroxidases. J AIDS Human Retrovirol, 1997; 15: 393-394.
58. Look MP, Rockstroh JK, Rao GS: Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr, 1997; 51: 266-272.
59. Baum MK, Cassetti LI, Bonvehi PE, et al: Inadequate dietary intake contributes to altered nutritional status in early HIV-1 infection. Nutrition, 1994; 10: 16-20.
60. Frost DV: Why the level of selenium in the food chain appears to be decreasing. In: Selenium in Biology and Medicine, Combs GF, et al., Eds. New York, AVI Van Nostrand. 1987, Part A, pp 534-547.
61. Rayman MP: Dietary selenium: time to act (editorial), British Med J, 1997; 314: 387.
62. Cowgill UM: The distribution of selenium and mortality owing to acquired immune deficiency syndrome in the continental United States. Biol Trace Element Res, 1997; 56: 43-61.
63. Michaelsson G, Berne B, Carlmark B, Strand A: Selenium in whole blood and plasma is decreased in patients with moderate and severe psoriasis. Acta Derm Venereol, 1989; 69: 29-34.